Equities

AiXin Life International Inc

AIXN:QBB

AiXin Life International Inc

Actions
  • Price (USD)0.28
  • Today's Change0.00 / 0.00%
  • Shares traded7.00
  • 1 Year change-91.44%
  • Beta0.9822
Data delayed at least 15 minutes, as of Apr 30 2024 15:51 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AiXin Life International Inc, formerly Mercari Communications Group Ltd, is a holding company mainly engaged in the provision of nutritional products in China. The Company operates its business through three segments. Advertising and Products segment provides health and wellness products and advertising and marketing services including herbs and greens, traditional Chinese remedies, functional products. Pharmacies segment distributes our health and wellness products. The Company also conduct through Hotels segment. The Company operates in the domestic market.

  • Revenue in USD (TTM)4.09m
  • Net income in USD-2.09m
  • Incorporated2001
  • Employees207.00
  • Location
    AiXin Life International IncHongxing Intl Business Building 2, 14Th Flr, No. 69, Qingyun Souve Ave.,CHENGDU 610021ChinaCHN
  • Phone+86 2 127397689
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Glucose Health Inc1.11m-456.46k6.65m2.00--7.02--5.98-0.033-0.0330.08030.0561-----------86.94---153.9547.1940.68-31.99-56.93313.11--0.00--98.3924.9416.87------
Kineta Inc5.44m-14.10m6.70m11.00--2.12--1.23-1.43-1.430.52970.2780.3927----494,727.30-101.57-66.16-318.39-86.61-----258.65-854.74---1,310.250.2011--178.6513.8977.76------
Scorpius Holdings Inc2.23m-46.05m6.70m77.00--0.1336--3.01-1.78-2.000.08591.390.0234--0.676228,918.57-50.05-38.42-61.25-42.0629.10---2,136.28-703.02----0.2305--202.1233.24-23.85--218.50--
Cannabis Bioscience Internatnl Hlgs Inc56.94m6.94m6.75m389.000.00120.00010.73150.11850.53280.53284.294.920.591762.811.45146,384.307.83--11.73--31.96--13.24--0.685650.750.0631--12.79--177.84------
Adial Pharmaceuticals Inc0.00-7.00m6.89m4.00--0.6925-----5.83-4.170.002.450.00----0.00-133.76-182.35-174.49-235.45-----------55.500.00------35.14------
Theriva Biologics Inc0.00-18.35m6.91m21.00--0.187-----1.15-1.150.002.310.00----0.00-28.88-36.95-32.40-40.16------------0.0056------8.37--95.91--
AiXin Life International Inc4.09m-2.09m7.00m207.00------1.71-0.0836-0.08360.1636-0.07650.82685.4310.0219,757.49-42.27-16.93---34.5416.2548.13-51.12-36.960.1515------51.0058.0867.18--194.59--
Calidi Biotherapeutics Inc0.00-28.74m7.04m38.00---------0.6324-0.63240.00-0.02410.00----0.00-284.51-----------------25.251.25---89.98---132.57------
Enveric Biosciences Inc0.00-17.46m7.15m7.00--1.37-----8.15-8.150.000.71420.00----0.00-144.99-104.94-207.98-156.88-------243.54----0.00------7.14------
Pulmatrix Inc7.30m-14.12m7.16m22.00--0.3978--0.9809-3.87-3.872.004.930.1948--6.56331,727.30-37.70-46.91-42.80-58.12-----193.49-238.04----0.00--20.21116.6225.03--104.29--
Kazia Therapeutics Ltd (ADR)14.91k-13.52m7.17m12.00--0.7789--480.98-0.8203-0.82030.00080.34920.0007--73.97---63.98-46.35-82.39-54.75-----90,714.45-497.17----0.1297--979.43-28.3118.19------
CV Sciences Inc16.00m3.10m7.18m42.002.132.452.150.44880.02060.02060.1040.0181.461.4626.74381,047.6028.28-43.42247.47-77.7544.2751.8119.38-45.680.373313.680.0805---1.24-19.80133.96-20.87----
MyMD Pharmaceuticals Inc0.00-7.07m7.18m9.00--0.3397-----5.53-5.530.0010.280.00----0.00-25.59-76.20-31.13-84.38--7.64---4,290.96----0.00------49.15------
Pasithea Therapeutics Corp0.00-15.51m7.21m8.00--0.308-----12.83-13.180.0022.460.00----0.00-43.50---46.44--------------0.00-------32.23------
Shuttle Pharmaceuticals Holdings Inc0.00-6.59m7.22m8.00--1.70-----0.441-0.4410.000.25240.00----0.00-90.28---104.75-------------49.560.1527-------112.71------
Intelligent Bio Solutions Inc2.46m-13.40m7.28m17.00--0.096--2.96-131.37-131.3720.9126.670.18312.419.09144,726.50-99.96-80.65-157.15-224.8420.90---545.95-948.540.3864--0.1602--187.51367.97-28.00------
Data as of Apr 30 2024. Currency figures normalised to AiXin Life International Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.